A masterclass webinar, focusing on the lessons learned from the 2022 Ovarian and Prostate Cancer EQA schemes, co-hosted by Dr. Simon Patton (CEO, EMQN) and Prof. Sandi Deans (Director, GenQA) is now available to view.
The webinar provides insight in to the challenges faced by laboratories when analysing samples for the germline and somatic variants (tissue and plasma) in patients with ovarian and prostate cancer. The hosts share their experience on how to ensure that you are able to provide robust high quality testing, accurate genotyping and appropriate clinical reporting.
Click HERE to view the recording.